| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |